Allarity Therapeutics is a biopharma company developing oncology products and drugs for the personalized treatment of cancer. The company uses Drug Response Predictor (DRP®) technology to advance therapeutic candidates by targeting and evaluating patient sub-populations having gene signatures. Its pipeline products include Dovitinib, Stenoparib, Ixempra, and other formulations. Allarity was incorporated in 2004 and is headquartered in Cambridge, MA.
What is Allarity Therapeutics's quote symbol?
What is the 52 week high and low for Allarity Therapeutics (NASDAQ: ALLR)?
How much is Allarity Therapeutics stock worth today?
How much is Allarity Therapeutics's stock price per share?
What is Allarity Therapeutics's Market Cap?